News Cronos continues cash burn with US$161M loss in Q1 With revenue of just US$12.6M in Q1, the Canadian pot firm says it's finally ready to commercialize its synthetic cannabinoids joint venture Jared GnamMay 7, 2021
The weed wire Amyris scales production of its first yeast-created cannabinoid Cannabigerol (CBG) shows higher efficacy in one-third of current CBD topical applications, company says Nick LabaSeptember 1, 2020
Cannabis 2.0 Creating cannabinoids from yeast: why it could mean trouble for extractors Biosynthetic cannabinoids use a fraction of extraction's cost, energy, water and biomass waste Michelle GamageJune 19, 2020